Amarin’s icosapent ethyl shows survival benefit in cancer trial

🌐 Investing.com (Cyprus) —
Amarin’s icosapent ethyl shows survival benefit in cancer trial

AI Summary

Amarin’s icosapent ethyl reportedly showed a survival benefit in a cancer clinical trial. The article provides no further details about the trial or the size of the benefit.

Markets Health Amarin icosapent ethyl cancer clinical trial survival benefit

Read original source →